Recently, there have been significant advances in the treatment of atopic dermatitis, including several new systemic therapeutic options overcoming regulatory hurdles. This has also been incorporated into the EuroGuiDerm guideline on the treatment of atopic eczema published last year. Thus, detailed guidance is included on the use of biologics and JAK inhibitors.
This content is machine-translated. Please contact us if you need professional translation services.
Publikation
- DERMATOLOGIE PRAXIS
